Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1979-3-13
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0041-1345
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
10
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
829-32
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:83717-Antibody Specificity,
pubmed-meshheading:83717-Antibody-Dependent Cell Cytotoxicity,
pubmed-meshheading:83717-B-Lymphocytes,
pubmed-meshheading:83717-Epitopes,
pubmed-meshheading:83717-Female,
pubmed-meshheading:83717-HLA Antigens,
pubmed-meshheading:83717-Histocompatibility Testing,
pubmed-meshheading:83717-Humans
|
pubmed:year |
1978
|
pubmed:articleTitle |
ADCC detects a public B-cell specificity broader than DRw3 and DRw6.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|